How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,129 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

221. Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder

Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder Pharmacological Treatments for Adult Patients With Major Depressive Disorder Comparative Effectiveness Review Number 161 Nonpharmacological Versus Comparative Effectiveness Review Number 161 Nonpharmacological Versus Pharmacological Treatments for Adult Patients With Major Depressive Disorder Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services (...) practice guidelines, other quality enhancement tools, or reimbursement or coverage policies, may not be stated or implied. This report may periodically be assessed for the currency of conclusions. If an assessment is done, the resulting surveillance report describing the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report. Persons using assistive technology may not be able to fully access information

2015 Effective Health Care Program (AHRQ)

222. Transcranial Magnetic Stimulation for the Treatment of Adults with PTSD, GAD, or Depression

or intermittent form and is thought to induce longer-lasting effects, while it is the intent of sTMS to identify the most optimal stimulation protocol for an individual patient in real-time. TMS was initially used to investigate nerve conduction. 13 It can be used as a tool for brain mapping, as a probe for neuronal networks, and as a modulator of brain function. 15 Clinically, brain stimulation has been found to improve symptoms of depression, 13 however due to the multifactorial nature of the intervention (...) , 2004 and September 30, 2014. Selection Criteria and Methods One reviewer screened citations and selected studies. In the first level of screening, titles and abstracts were reviewed and potentially relevant articles were retrieved and assessed for inclusion. The final selection of full-text articles was based on the inclusion criteria presented in Table 1. Transcranial Magnetic Stimulation for the Treatment of Adults with PTSD, GAD, or Depression 2 Table 1: Selection Criteria Population Adults

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

223. Neuro-Linguistic Programming for the Treatment of Adults with Post-Traumatic Stress Disorder, General Anxiety Disorder, or Depression

gathering and desired health outcome definition, and use of techniques and tools such as sets of questions to facilitate a change in thinking and behavior of patients. 11 Therapy sessions can take place weekly with the total number of sessions depending on individual needs. This Rapid Response report aims to review the clinical evidence of NLP for PTSD, GAD and depression. Evidence-based guidelines on the use of NLP for these disorders will also be examined. RESEARCH QUESTIONS 1. What is the clinical (...) reviewer screened citations and selected studies. In the first level of screening, titles and abstracts were reviewed for relevance. Full texts of any relevant titles or abstracts were retrieved, and assessed for inclusion. The final article selection was based on the inclusion criteria presented in Table 1. Table 1: Selection Criteria Population Adults with PTSD, GAD, or depression Intervention NLP Comparator No comparator Standard therapy Outcomes Clinical effectiveness and benefit Guidelines Study

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

224. Depression in Multiple Sclerosis

NOT formally screen each patient for depression (i.e., with depression assessment tools). ? If depression is suspected, consider inquiring about mood, anhedonia, irritability and suicidal thoughts. ? Perform a more detailed clinical assessment if depression is suspected. o A depression screening tool can be used to inform clinical diagnosis, but should not be the only source used. ? The following tools are suggested: ? PHQ-9 (http://tinyurl.com/http-tinyurl-com-PHQ-9) – a short, easy to use, well known (...) and common tool in the public domain, or ? Another preferred depression screening tool, or ? One of the screening tool options listed in Appendix A Note: The tool selected can provide a baseline measure of depression and serve to assess treatment progress. DIAGNOSIS ? Diagnose depression in the MS patient as per usual process for diagnosing depression. X DO NOT formally screen every patient taking interferon ß even though in the past it has been implicated as a cause of depression – the same principles

2015 Accelerating Change Transformation Team

225. Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes (Abstract)

Sensitivity of the DN4 in Screening for Neuropathic Pain Syndromes Several tools have been developed to screen for neuropathic pain. This study examined the sensitivity of the Douleur Neuropathique en 4 Questions (DN4) in screening for various neuropathic pain syndromes.This prospective observational study was conducted in 7 Canadian academic pain centers between April 2008 and December 2011. All newly admitted patients (n=2199) were approached and 789 eligible participants form the sample (...) for this analysis. Baseline data included demographics, disability, health-related quality of life, and pain characteristics. Diagnosis of probable or definite neuropathic pain was on the basis of history, neurological examination, and ancillary diagnostic tests.The mean age of study participants was 53.5 years and 54.7% were female; 83% (n=652/789) screened positive on the DN4 (≥4/10). The sensitivity was highest for central neuropathic pain (92.5%, n=74/80) and generalized polyneuropathies (92.1%, n=139/151

2018 EvidenceUpdates

226. Rates of detection of developmental problems at the 18-month well-baby visit by family physicians' using four evidence-based screening tools compared to usual care: a randomized controlled trial. Full Text available with Trip Pro

Rates of detection of developmental problems at the 18-month well-baby visit by family physicians' using four evidence-based screening tools compared to usual care: a randomized controlled trial. Early and regular developmental screening can improve children's development through early intervention but is insufficiently used. Most developmental problems are readily evident at the 18-month well-baby visit. This trial's purpose is to: (1) compare identification rates of developmental problems (...) by GPs/family physicians using four evidence-based tools with non-evidence based screening, and (2) ascertain whether the four tools can be completed in 10-min pre-visit on a computer.We compared two approaches to early identification via random assignment of 54 families to either: 'usual care' (informal judgment including ad-hoc milestones, n = 25); or (2) 'Evidence-based' care (use of four validated, accurate screening tools, n = 29), including: the Parents' Evaluation of Developmental Status (PEDS

2016 Child: care, health and development Controlled trial quality: uncertain

227. Preliminary Evaluation of a Modified STarT Back Screening Tool Across Different Musculoskeletal Pain Conditions. Full Text available with Trip Pro

Preliminary Evaluation of a Modified STarT Back Screening Tool Across Different Musculoskeletal Pain Conditions. The STarT Back Screening Tool is a validated multidimensional screening measure and risk stratification tool for people with low back pain.The study objective was to compare relationships between a modified STarT Back Screening Tool (mSBT) and clinical and psychological measures in people with low back, neck, shoulder, and knee pain. The hypothesis was that the relationships between (...) (kinesiophobia, catastrophizing, fear avoidance, anxiety, depressive symptoms, and self-efficacy) measures as dependent variables. Demographic and pain region variables were entered in the first step, mSBT scores were entered in the second step, and pain region × mSBT interactions were entered in the last step.In the final models, no interactions were identified, suggesting that dependent measure scores did not differ by pain region. The strongest contributor for all dependent variables was mSBT scores (β

2016 Physical therapy

228. Sensation seeking as a potential screening tool for suicidality in adolescence. Full Text available with Trip Pro

Sensation seeking as a potential screening tool for suicidality in adolescence. Although suicide could be an adverse health problem related to sensation seeking, this relationship has not been rigorously evaluated. The purpose of this study was to evaluate the relationship between sensation seeking and suicidality (suicidal ideation and plan) among adolescents and to test the influence of depressive symptom on this relationship.We surveyed 2,017 adolescents in seven middle and high schools (...) located in urban and rural areas in 2012. A self-report questionnaire included items about demographic characteristics, sensation seeking, depressive symptom, and suicide plans. We evaluated the influence of sensation seeking on suicide plan using multiple logistic regression and causal mediation analysis.Sensation seeking was related to suicide ideation and plan. Sensation seeking was associated with a 13 % greater likelihood of a suicide plan during the past 12 months as the score increased by 1

2016 BMC Public Health

229. Assessing the Construct Validity and Internal Reliability of the Screening Tool Test Your Memory in Patients with Chronic Pain Full Text available with Trip Pro

Assessing the Construct Validity and Internal Reliability of the Screening Tool Test Your Memory in Patients with Chronic Pain Patients with chronic pain often complain about cognitive difficulties, and since these symptoms represent an additional source of suffering and distress, evaluating the cognitive status of these patients with valid and reliable tests should be an important part of their overall assessment. Although cognitive impairment is a critical characteristic of pain (...) Examination (MMSE), Hospital Anxiety and Depression Scale (HADs), Index-9 from MOS-sleep, SF-12, and through the intensity (Visual Analogical Scale) and duration of pain. An exploratory factor analysis was also performed and internal reliability was assessed using Cronbach's alpha. After adjusting for potential confounders the TYM could distinguish between pain and pain-free patients, and it was correlated with the: MMSE (0.89, p<0.001); HAD-anxiety (-0.50, p<0.001) and HAD-depression scales (-0.52, p

2016 PloS one

230. Standardization of a Novel Self-administered Tablet Computer-based Clinical Screening Tool for Adverse Postoperative Cognitive Outcomes

Standardization of a Novel Self-administered Tablet Computer-based Clinical Screening Tool for Adverse Postoperative Cognitive Outcomes Standardization of a Novel Self-administered Tablet Computer-based Clinical Screening Tool for Adverse Postoperative Cognitive Outcomes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning (...) You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Standardization of a Novel Self-administered Tablet Computer-based Clinical Screening Tool for Adverse Postoperative Cognitive Outcomes (CogCheck-Norm) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov

2016 Clinical Trials

231. Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus. (Abstract)

metrics for depression and anxiety in SLE patients.Anxiety and depression are highly prevalent in patients with SLE. Patient-reported outcome questionnaires such as the CES-D, HADS, and BAI may be useful tools to screen for depression and anxiety in SLE. Our results suggest that SLE-specific cut-offs may improve diagnostic accuracy of current screening metrics in patients with lupus.Copyright © 2019 Elsevier Inc. All rights reserved. (...) ) evaluate their diagnostic accuracy when compared to the assessment of an independent psychiatric assessment using the Mini-International Neuropsychiatric Interview (MINI).159 consecutive SLE participants were screened for depression and anxiety using the CES-D, HADS, and BAI, and underwent the MINI. Sensitivity and specificity were evaluated against the MINI. Test-retest reliability was studied. Receiver operator characteristic (ROC) curves were utilized to determine the cut-off scores for CES-D, HADS

2019 Seminars in arthritis and rheumatism

232. Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression. Full Text available with Trip Pro

Guided Self-Help Works: Randomized Waitlist Controlled Trial of Pacifica, a Mobile App Integrating Cognitive Behavioral Therapy and Mindfulness for Stress, Anxiety, and Depression. Despite substantial improvements in technology and the increased demand for technology-enabled behavioral health tools among consumers, little progress has been made in easing the burden of mental illness. This may be because of the inherent challenges of conducting traditional clinical trials in a rapidly evolving (...) technology landscape.This study sought to validate the effectiveness of Pacifica, a popular commercially available app for the self-management of mild-to-moderate stress, anxiety, and depression.A total of 500 adults with mild-to-moderate anxiety or depression were recruited from in-app onboarding to participate in a randomized waitlist controlled trial of Pacifica. We conducted an all-virtual study, recruiting, screening, and randomizing participants through a Web-based participant portal. Study

2019 Journal of medical Internet research Controlled trial quality: uncertain

233. Novel Health Information Technology to Aid Provider Recognition and Treatment of Major Depressive Disorder and Posttraumatic Stress Disorder in Primary Care. (Abstract)

Novel Health Information Technology to Aid Provider Recognition and Treatment of Major Depressive Disorder and Posttraumatic Stress Disorder in Primary Care. Millions of traumatized refugees worldwide have resettled in the United States. For one of the largest, the Cambodian community, having their mental health needs met has been a continuing challenge. A multicomponent health information technology screening tool was designed to aid provider recognition and treatment of major depressive (...) for depression and 34% screened positive for PTSD. Multilevel mixed effects logistic models, accounting for clustering structure, indicated that providers in the intervention were more likely to diagnose depression [odds ratio (OR), 6.5; 95% confidence interval (CI), 1.48-28.79; P=0.013] and PTSD (OR, 23.3; 95% CI, 2.99-151.62; P=0.002) among those diagnosed during screening, relative to the control group. Providers in the intervention were more likely to provide evidence-based guideline (OR, 4.02; 95% CI

2019 Medical Care Controlled trial quality: predicted high

234. Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression. (Abstract)

Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression. Although several pharmacological treatment options for depression are currently available, a large proportion of patients still do not achieve a complete remission or respond adequately to the initial antidepressant prescribed for reasons that remain relatively unknown. This study explored the application of serum biomarkers to the predict the efficacy of escitalopram for treating depression (...) , to guide clinical drug selection.In this study, 306 patients suffering from depression were treated with escitalopram (10 mg) for 6 weeks. After 6 weeks of treatment, the patients were divided into an escitalopram-sensitive group (ES, n = 172) and an escitalopram-insensitive group (EIS, n = 134) according their HAMD-24 scores after 6 weeks of treatment. Serum samples from all participants were collected on the first day, and 10 different serum biomarkers were analysed. Data from 100 patients in the ES

2019 Journal of Affective Disorders

235. Re-examination of perinatal mental health policy frameworks for women signalling distress on the Edinburgh Postnatal Depression Scale (EPDS) completed during their antenatal booking-in consultation: a call for population health intervention. Full Text available with Trip Pro

risk factor for developing postnatal depression. Research in this space has focused on treatment of postnatal depression, with limited attention paid to preventative strategies for women signalling distress, who are subthreshold for diagnosable illness.The Edinburgh Postnatal Depression Scale (EPDS) was introduced in 1987 and has since been validated as a depression screening tool in the Australian and international setting. The EPDS has been embedded as a depression screening tool within a broader (...) Re-examination of perinatal mental health policy frameworks for women signalling distress on the Edinburgh Postnatal Depression Scale (EPDS) completed during their antenatal booking-in consultation: a call for population health intervention. Globally, anxiety and depression are the most common complications of the perinatal period (conception to 1 year postpartum). It is now recognised that anxiety and depression are more commonly found antenatally than postnatally and represent the greatest

2019 BMC Pregnancy and Childbirth

236. Depression and social support among breast cancer patients in Addis Ababa, Ethiopia. Full Text available with Trip Pro

cancer patients was conducted in seven health facilities in Addis Ababa, Ethiopia. Depression and Social Support were assessed using standard tools Patient Health Questionnaire 9 (PHQ 9) and Multidimensional Scale of Perceived Social Support (MSPSS) respectively. Descriptive statistics were done based on the standard PHQ9 cut off points (0-4, 5-9, 10-14, 15-19 and ≥ 20). Mann-Whitney and Kruskal Wallis tests were employed to compare MSPSS score among depressed and non-depressed patients and across (...) with employer/ family were significantly associated with depression. The participants' MSPSS total score was overall found to be high (70.35 ± 16.81). Those women who had moderate and severe depression had lower mean MSPSS scores compared to women with none/ minimal depression (P = 0.002).This study found that one in four breast cancer patients had depression. Depression is associated with poor social support given by family, friends and significant others. Therefore, screening for depression

2019 BMC Cancer

237. How does stress, depression and anxiety affect patients undergoing treatment? (Abstract)

How does stress, depression and anxiety affect patients undergoing treatment? To review latest findings about the impact of fertility care on emotional distress and effect of distress on treatment outcome.Treatment failure and long agonist protocols are associated with increased emotional distress during treatment. Screening tools can be used to identify men and women at risk of emotional maladjustment at the start of fertility treatment and people unlikely to need emotional support during (...) or after treatment. There are inconclusive results about the association between emotional distress and outcome of fertility treatment. Systematic review of studies evaluating the effect of psychological and educational interventions on anxiety, depression and live birth (or ongoing pregnancy) are uninformative because of clinical heterogeneity and risk of bias.ART is emotionally demanding, patients that adapt more poorly can be identified in advance. Fertility staff should follow good practice

2019 Current Opinion in Obstetrics and Gynecology

238. Depression in Emergency Department Patients and Association with Healthcare Utilization. (Abstract)

prospective cohort study enrolled a convenience sample of English-speaking adults presenting to an urban academic medical center ED without psychiatric complaints between January 1, 2015, and September 21, 2015. Patients completed a computerized adaptive depression diagnostic screen (CAD-MDD) and dimensional depression severity measurement test (CAT-DI) via tablet computer. Primary outcomes included number of ED visits and hospitalizations assessed from index visit until January 1, 2016. Negative binomial (...) regression modeling was performed to assess associations between depression, depression severity, clinical covariates, and utilization outcomes.Of 999 enrolled patients, 27% screened positive for MDD. The presence of MDD conveyed a 61% increase in the rate of ED visits (incidence rate ratio [IRR] = 1.61, 95% confidence interval [CI] = 1.27 to 2.03) and a 49% increase in the rate of hospitalizations (IRR = 1.49, 95% CI = 1.06-2.09). For each 10% increase in MDD severity, there was a 10% increase

2019 Academic Emergency Medicine

239. Depression among HIV positive pregnant women in Zimbabwe: a primary health care based cross-sectional study. Full Text available with Trip Pro

in Zimbabwe.We carried out a cross-sectional study in 4 busy primary care clinics offering antenatal services during the months of June through to September in 2016. Simple random sampling was used to screen HIV positive pregnant women while they waited to be attended to at each clinic. Eligible women who gave written informed consent were screened using a locally validated screening tool-the Edinburgh Postnatal Depression Scale (EPDS).A total of 198(85%) participants were recruited out of 234 that were (...) in primary care clinics is high. Factors associated with antenatal depression in pregnant HIV positive women are IPV and previous history of depression. There is need for routine screening for depression during the antenatal period and interventions targeting depression in this population should include components to address IPV.

2019 BMC Pregnancy and Childbirth

240. Management of Depression in Older Adults: A Review. (Abstract)

of antidepressant medication that are used for younger adult patients. Although antidepressants may effectively treat depression in older adults, they tend to pose greater risk for adverse events because of multiple medical comorbidities and drug-drug interactions in case of polypharmacy. High-quality evidence does not support the use of pharmacologic treatment of depression in patients with dementia. Polypharmacy in older patients can be minimized by using the Screening Tool of Older Persons Prescriptions (...) and Screening Tool to Alert doctors to Right Treatment (STOPP/START) criteria, a valid and reliable screening tool that enables physicians to avoid potentially inappropriate medications, undertreatment, or errors of omissions in older people. Antidepressants can be gradually tapered over a period of several weeks, but discontinuation of antidepressants may be associated with relapse or recurrence of depression, so the patient should be closely observed.Major depression in older adults is common and can

2017 JAMA

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>